Over the counter and prescription-only medication misuse is of concern. Little is known about the impact on friends/family who provide individuals with support. It is important to increase understanding to identify how substance misuse services (SMS) and others can better meet their needs. The aim is to explore the impact of over the counter and prescription-only medication misuse on friends/family and improve an understanding of how this may be reduced.
Methods
Ethical approval was obtained and confidential semi-structured interviews were undertaken with a modified grounded theory approach. Participants were recruited from community adult SMS in England. Verbatim transcripts underwent thematic analysis using NVIVO, and findings are reported in line with COREQ.
Results
Eight telephone interviews (62.5% female) included a variety of different friend/relative relationships. Data saturation was felt to have been achieved, and identified that friends/family were significantly impacted, in long-standing and varying negative ways. Five themes were identified: impact on finances; impact of managing side-effects/withdrawal symptoms; impact on relationships; treatment interventions and personal support. Especially due to the psychological burden, friends/family benefit from holistic support, including improved awareness of over the counter and prescription-only medication misuse and interventions from healthcare/SMS providers, social services, affected others and their personal support network. Relationships where honesty and openness are encouraged, enable friends/family to provide more support and advocacy.
Conclusions
Care providers should include friends/family when delivering holistic interventions. They should be vigilant for safeguarding issues and the impact on children, and improve approaches to withdrawal symptom/side-effect management, medicines optimisation and service responsiveness. Future research should include more participants and other SMS.
AliMMujahidABulathsinghalaCP, et al. (2020) Cardiac arrhythmia secondary to loperamide abuse and toxicity. Cureus12(2): e6936.
5.
BarrettSPMeisnerJRStewartSH (2008) What constitutes prescription drug misuse: Problems and pitfalls of current conceptualizations. Current Drug Abuse Reviews1(3): 255-262.
6.
BohnertASEisenbergAWhitesideL, et al. (2013) Prescription opioid use among addictions treatment patients: Nonmedical use for pain relief vs. other forms of nonmedical use. Addictive Behaviors38(3): 1776-1781.
7.
BraunVClarkeV (2006) Using thematic analysis in psychology. Qualitative Research in Psychology3(2): 77-101.
8.
BrodMTeslerLEChristensenTL (2009) Qualitative research and content validity: Developing best practices based on science and experience. Quality of Life Research18(9): 1263-1278.
9.
ButlerSFBlackRASerranoJM, et al. (2010) Characteristics of prescription opioid abusers in treatment: Prescription opioid use history, age, use patterns, and functional severity. Journal of Opioid Management6(4): 239-241.
10.
CarballoJLFernández-HermidaJRSecades-VillaR, et al. (2007) Natural recovery from alcohol and drug problems: A methodological review of the literature from 1999 through 2005. In: KlingemannHSobellL (eds) Promoting Self-Change from Addictive Behaviors. Boston, MA: Springer, 87-101.
11.
ChanGMStajicMMarkerEK, et al. (2006) Testing positive for methadone and either a tricyclic antidepressant or a benzodiazepine is associated with an accidental overdose death: Analysis of medical examiner data. Academic Emergency Medicine13(5): 543-547.
12.
Committee on Health Care for Underserved Women, The American College of Obstetricians and Gynecologists (AOG). (2012) Committee opinion no. 538: Nonmedical use of prescription drugs. Obstetrics and Gynecology120(4): 977-982.
13.
CoombesHCooperRJ (2019) Staff perceptions of prescription and over-the-counter drug dependence services in England: A qualitative study. Addiction Science & Clinical Practice14(1): 41.
CooperRJ (2013) ‘I can’t be an addict. I am.’ over-the-counter medicine abuse: A qualitative study. BMJ Open3(6): e002913.
16.
CooperSNielsenS (2017) Stigma and social support in pharmaceutical opioid treatment populations: A scoping review. Int J Ment Health Addiction15: 452-469.
GibbsG (2002) Qualitative Data Analysis: Explorations with NVivo. Buckingham: Open University Press.
21.
GittinsRColeS (2021) Buprenorphine for the management of kratom dependency during COVID-19: A case report. Drug Science, Policy and Law7. https://doi.org/10.1177/20503245211021193.
22.
GittinsRGuirguisASchifanoF, et al. (2018) Exploration of the use of new psychoactive substances by individuals in treatment for substance misuse in the UK. Brain Sciences8(4): 58.
23.
GittinsRMissenLMaidmentI (2022a) Misuse of Over the Counter and Prescription Only Medication by Adults Accessing Specialist Treatment Services in the UK: A Narrative Synthesis. Substance Abuse 16. https://doi.org/16:11782218221111833.
24.
GittinsRTay Wee TeckJMadillA (2022c) Examining the gender dimension in the non-medical use of over the counter and prescription only medication. Drug Science, Policy and Law8. https://doi.org/10.1177/20503245221132548.
25.
GittinsRVaziriRMaidmentI (2022b) Surveying over the counter and prescription only medication misuse in treatment services during COVID-19. Substance Abuse: Research and Treatment16:117822182211358.
26.
GossopMMoosR (2008) Substance misuse among older adults: A neglected but treatable problem. Addiction103(3): 347-348.
27.
GuestGBunceAJohnsonL (2006) How many interviews are enough?: An experiment with data saturation and variability. Field Methods18(1): 59-82.
JonesJDMogaliSComerSD (2012) Polydrug abuse: A review of opioid and benzodiazepine combination use. Drug and Alcohol Dependence125(1-2): 8-18.
30.
KirschbaumMBarnettTCrossM (2020) Experiences of over-the-counter codeine misusers and accounts of recovery: A qualitative study in Tasmania, Australia. Drug and Alcohol Review39(7): 879-887.
31.
LanderLHowsareJByrneM (2013) The impact of substance use disorders on families and children: From theory to practice. Social Work in Public Health28(3-4): 194-205.
32.
LyndonAAudreySWellsC, et al. (2017) Risk to heroin users of polydrug use of pregabalin or gabapentin. Addiction112(9): 1580-1589.
33.
MacleodJSteerCTillingK, et al. (2019) Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK clinical practice research datalink and office for national statistics death records. PLOS Medicine16(11): e1002965.
34.
ManthorpeJMoriartyJCornesM (2015) Supportive practice with carers of people with substance misuse problems. Practice: Social Work in Action27(1): 51-65.
35.
MarsdenJWhiteMAnnandF, et al. (2019) Medicines associated with dependence or withdrawal: A mixed-methods public health review and national database study in England. The Lancet Psychiatry6(11): 935-950.
National Institute for Health and Social Care Excellence (NICE). (2022) Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults. https://www.nice.org.uk/guidance/ng215.
38.
NielsenSCameronJPahokiS (2010) Final Report: Over the Counter Codeine Dependence. Victoria: Turning Point Alcohol and Drug Centre.
39.
NobleSMHollingworthWTillingK (2012) Missing data in trial based cost-effectiveness analysis: The current state of play. Health Economics21(2): 187-200.
PvAAbdinEJun WenT, et al. (2018) Correlates of non-medical prescription drug misuse among a treatment-seeking population: A comparison with illicit drug users. International Journal of Environmental Research and Public Health15(9): 1978.
SharmaNChakrabartiSGroverS (2016) Gender differences in caregiving among family - caregivers of people with mental illnesses. World Journal of Psychiatry6(1): 7-17.
48.
SmithSMDartRCKatzNP, et al. (2013) Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain154(11): 2287-2296.
49.
TongASainsburyPCraigJ (2007) Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care19(6): 349-357.
Van AmsterdamJGNabbenTKeimanD, et al. (2015) Exploring the attractiveness of new psychoactive substances (NPS) among experienced drug users. Journal of Psychoactive Drugs47(3): 177-181.
52.
Van HoutMCBinghamT (2012) “A costly turn on”: Patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors. International Journal of Drug Policy23(3): 188-197.
53.
Van HoutMCBrennanR (2011) ‘Heads held high’: An exploratory study of legal highs in Pre-legislation Ireland’. Journal of Ethnicity in Substance Abuse10(3): 256-272.
54.
Van HoutMCHoranASantlalK, et al. (2018) ‘Codeine is my companion': Misuse and dependence on codeine containing medicines in Ireland. Irish Journal of Psychological Medicine35(4): 275-288.
